Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium
Year: 2023
Type: article
Study design: Observational Study
Source: Oncogene
Authors: Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, Christine Schilhart-Wallisch, Georg Heinze, Wei-Lei Yang, Robert C. Bast, Jalid Sehouli, Elena I. Braicu, Ignace Vergote, Toon Van Gorp, Sven Mahner, Valentina Paspalj, Christoph Grimm, Eva Obermayr, Eva Schuster, Barbara Holzer, Frederic Rousseau, Joost Schymkowitz, Nicole Concin, Robert Zeillinger
Institutions: Comprehensive Cancer Center Vienna, Medical University of Vienna, VIB-KU Leuven Center for Brain & Disease Research, KU Leuven, Innsbruck Medical University, Universität Innsbruck, The University of Texas MD Anderson Cancer Center, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, Stanford University, Universitair Ziekenhuis Leuven, University Medical Center Hamburg-Eppendorf, Ludwig-Maximilians-Universität München
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W4383101084